Clinical Drugs Undergoing Polymorphic Metabolism by Human Cytochrome P450 2C9 and the Implication in Drug Development

E-ISSN： 1875-533x|18|5|667-713

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.5, 2011-02, pp. : 667-713

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development

Current Medicinal Chemistry, Vol. 16, Iss. 27, 2009-09 ,pp. : 3480-3675

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 2C8 and Drug Metabolism

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 18, 2013-09 ,pp. : 2241-2253

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphism of the Human Cytochrome P450 2C9 Gene and Its Clinical Significance

Current Drug Metabolism, Vol. 10, Iss. 7, 2009-09 ,pp. : 781-834

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs: Clinical Relevance

By Kirchheiner Julia Roots Ivar Goldammer Mark Rosenkranz Bernd

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1209-1225

Adis International

Access to resources Recommend Favorite

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

By Ingelman-Sundberg M. Oscarson M. McLellan R.A.

Trends in Pharmacological Sciences, Vol. 20, Iss. 8, 1999-08 ,pp. : 342-349

Elsevier

Access to resources Recommend Favorite